Dr Reddy’s gets 30 days to sell ‘Olymviq’ stock in Novo trademark case Vimal Sharma 7 hours ago Dr Reddy’s has agreed to rebrand semaglutide drug amid a dispute with Novo Nordisk. Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X
